Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Genes controlling hair growth and immune response are disrupted in male pattern baldness.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Mineral levels in hair don't significantly affect the severity of atopic dermatitis in children.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

The electronic version of the Dermatology Life Quality Index is as effective as the paper version, with most patients preferring it.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Soy supplements improve various skin conditions and aging signs, with topical use boosting skin barrier function.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Different staff in a dermatology clinic understand mostly their own tasks, not the full clinic process.

Low-level laser therapy may help with hair regrowth in alopecia areata but its effectiveness for psoriasis and atopic dermatitis needs more research.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Severe Hidradenitis Suppurativa increases missed and unproductive workdays.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Apremilast shows promise for several skin conditions but needs more research.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Cannabinoids may help some skin conditions but more research is needed.